2020 Symposium on ALS - Clinical Conversations Panel

Clinical Conversations Panel And Closing Remarks At Les Turner Symposium On Als

Clinical Conversations Panel

Clinical Conversations Panel

2020 Symposium On Als: Tania Gendron, Phd - "on Mechanisms And Markers Of Als”

2020 Symposium On Als, Robert Kalb, Md: Neurons & Pathogenic Metabolic Reprograming In Familial Als

2020 Symposium On Als - Keynote Address: Sabrina Paganoni, Md, Phd - The Healey Als Platform Trial

2020 Symposium On Als: Hande Ozdinler, Phd, Northwestern University

2020 Symposium On Als: Brian Kraemer, Phd, Northwestern University

2020 Symposium On Als: Evangelos Kiskinis, Phd - Novel Insights Into The Molecular Mechanisms ...

We Are The Les Turner Als Foundation

2020 Symposium On Als: Magdalini Polymenidou, University Of Zurich

Clinical Management For Als: Diagnosis, Treatment And Clinical Trials

Andrea Pauls Backman, Ceo, Les Turner Als Foundation: Meeting The Challenges Of Als Through Covid 19

Dr. Senda Ajroud-driss On Collaborative Between Northwestern Medicine And Les Turner Als Foundation

Protein Aggregation And The Development Of Nu-9 For Upper Motor Neuron Diseases, Including Als

Keynote Presentation At 2022 Les Turner Symposium On Als

Als Learning Series: Genetics And Als

Overview Of Als: Pathophysiology, Mechanism And Science Of Treatment